DHC vs SBRA

For growth investors, Sabra Health Care REIT, Inc.

(SBRA) is the stronger pick with 10. 2% revenue growth year-over-year, versus 2. 8% for Diversified Healthcare Trust (DHC). Sabra Health Care REIT, Inc. (SBRA) offers the better valuation at 32. 2x trailing P/E (29. 8x forward), making it the more compelling value choice. Analysts rate Diversified Healthcare Trust (DHC) a "Hold" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Diversified Healthcare Trust (DHC) delivered a total return of +109.

9%, compared to +49. 9% for Sabra Health Care REIT, Inc. (SBRA). Over 10 years, the gap is even starker: SBRA returned +50. 9% versus DHC's -29. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Sabra Health Care REIT, Inc.

(SBRA) is the lower-risk stock at -0. 06β versus Diversified Healthcare Trust's 0. 55β — meaning DHC is approximately -946% more volatile than SBRA relative to the S&P 500. On balance sheet safety, Sabra Health Care REIT, Inc. (SBRA) carries a lower debt/equity ratio of 90% versus 145% for Diversified Healthcare Trust — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Sabra Health Care REIT, Inc.

(SBRA) is pulling ahead at 10. 2% versus 2. 8% for Diversified Healthcare Trust (DHC). On earnings-per-share growth, the picture is similar: Diversified Healthcare Trust grew EPS 23. 2% year-over-year, compared to 18. 5% for Sabra Health Care REIT, Inc.. Over a 3-year CAGR, SBRA leads at 7. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Sabra Health Care REIT, Inc.

(SBRA) is the more profitable company, earning 20. 1% net margin versus -18. 6% for Diversified Healthcare Trust — meaning it keeps 20. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SBRA leads at 34. 1% versus -2. 6% for DHC. At the gross margin level — before operating expenses — SBRA leads at 65. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for DHC: 17.

4% to $9. 50.

All stocks in this comparison pay dividends.

Sabra Health Care REIT, Inc. (SBRA) offers the highest yield at 5. 8%, versus 0. 5% for Diversified Healthcare Trust (DHC).

For long-horizon retirement investors, Sabra Health Care REIT, Inc.

(SBRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 06), 5. 8% yield). Both have compounded well over 10 years (SBRA: +50. 9%, DHC: -29. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: DHC is a small-cap quality compounder stock; SBRA is a small-cap income-oriented stock. SBRA pays a dividend while DHC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.